AntagomiR-103 and -107 Treatment Affects Cardiac Function and Metabolism

MLA

Monika Rech, et al. “AntagomiR-103 and -107 Treatment Affects Cardiac Function and Metabolism.” Molecular Therapy: Nucleic Acids, vol. 14, no. 424–437, Mar. 2019, pp. 424–37. EBSCOhost, https://doi.org/10.1016/j.omtn.2018.12.010.

APA

Monika Rech, Annika R. Kuhn, Joost Lumens, Paolo Carai, Rick van Leeuwen, Wouter Verhesen, Robin Verjans, Julie Lecomte, Yilin Liu, Joost J.F.P. Luiken, Ronny Mohren, Berta Cillero-Pastor, Stephane Heymans, Kèvin Knoops, Marc van Bilsen, & Blanche Schroen. (2019). AntagomiR-103 and -107 Treatment Affects Cardiac Function and Metabolism. Molecular Therapy: Nucleic Acids, 14(424–437), 424–437. https://doi.org/10.1016/j.omtn.2018.12.010

Chicago

Monika Rech, Annika R. Kuhn, Joost Lumens, Paolo Carai, Rick van Leeuwen, Wouter Verhesen, Robin Verjans, et al. 2019. “AntagomiR-103 and -107 Treatment Affects Cardiac Function and Metabolism.” Molecular Therapy: Nucleic Acids 14 (424–437): 424–37. doi:10.1016/j.omtn.2018.12.010.